Ribera E - Search Results

1

Management of tuberculosis in HIV-infected patients.

Curran A, Falcó V, Pahissa A, Ribera E. Curran A, et al. Among authors: ribera e. AIDS Rev. 2012 Oct-Dec;14(4):231-46. AIDS Rev. 2012. PMID: 23258298 Review.

2

Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.

Falcó V, Rodríguez D, Ribera E, Martínez E, Miró JM, Domingo P, Diazaraque R, Arribas JR, González-García JJ, Montero F, Sánchez L, Pahissa A. Falcó V, et al. Among authors: ribera e. Clin Infect Dis. 2002 Mar 15;34(6):838-46. doi: 10.1086/339041. Epub 2002 Feb 13. Clin Infect Dis. 2002. PMID: 11850865

3

Lactic acidosis related to nucleoside therapy in HIV-infected patients.

Falcó V, Crespo M, Ribera E. Falcó V, et al. Among authors: ribera e. Expert Opin Pharmacother. 2003 Aug;4(8):1321-9. doi: 10.1517/14656566.4.8.1321. Expert Opin Pharmacother. 2003. PMID: 12877640 Review.

4

Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or less.

Ferrer E, Santamariña E, Domingo P, Fumero E, Ribera E, Knobel H, Lopez JC, Barrios A, Podzamczer D. Ferrer E, et al. Among authors: ribera e. AIDS. 2004 Aug 20;18(12):1727-9. doi: 10.1097/01.aids.0000131381.07609.19. AIDS. 2004. PMID: 15280785

5

Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.

Ribera E, Lopez RM, Diaz M, Pou L, Ruiz L, Falcó V, Crespo M, Azuaje C, Ruiz I, Ocaña I, Clotet B, Pahissa A. Ribera E, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4256-62. doi: 10.1128/AAC.48.11.4256-4262.2004. Antimicrob Agents Chemother. 2004. PMID: 15504850 Free PMC article. Clinical Trial.

6

[Efavirenz and nevirapine plasma levels in HIV-infected patients with hemophilia].

Martorell M, López RM, Ribera E, Ruiz I, Tural C, Puig L, Monterde J. Martorell M, et al. Among authors: ribera e. Enferm Infecc Microbiol Clin. 2005 Jun-Jul;23(6):349-52. doi: 10.1157/13076174. Enferm Infecc Microbiol Clin. 2005. PMID: 15970167 Spanish.

7

Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.

Ribera E, Rodríguez-Pardo D, Rubio M, Soler A, Pedrol E, Blanco JL, González A, Crespo M, Falcó V, Ocaña I, Deig E, Miró JM, Pahissa A. Ribera E, et al. Antivir Ther. 2005;10(5):605-14. Antivir Ther. 2005. PMID: 16152754 Clinical Trial.

8

Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).

Ribera E, Azuaje C, Lopez RM, Domingo P, Soriano A, Pou L, Sánchez P, Mallolas J, Sambea MA, Falco V, Ocaña I, Lopez-Colomes JL, Gatell JM, Pahissa A. Ribera E, et al. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):317-23. doi: 10.1097/01.qai.0000182629.74336.4d. J Acquir Immune Defic Syndr. 2005. PMID: 16249706 Clinical Trial.

9

Value of culture and nested polymerase chain reaction of blood in the prediction of relapses in patients co-infected with leishmania and human immunodeficiency virus.

Riera C, Fisa R, Ribera E, Carrió J, Falcó V, Gállego M, Moner L, Molina I, Portús M. Riera C, et al. Among authors: ribera e. Am J Trop Med Hyg. 2005 Dec;73(6):1012-5. Am J Trop Med Hyg. 2005. PMID: 16354803

10

Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen.

Ribera E, Azuaje C, Lopez RM, Diaz M, Feijoo M, Pou L, Crespo M, Curran A, Ocaña I, Pahissa A. Ribera E, et al. AIDS. 2006 May 12;20(8):1131-9. doi: 10.1097/01.aids.0000226953.56976.ad. AIDS. 2006. PMID: 16691064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page